Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options. [PDF]
Ballerini A+12 more
europepmc +1 more source
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. [PDF]
Douglas R. Rosing+3 more
openalex +1 more source
Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta+5 more
wiley +1 more source
Classification, Diagnosis, and Prognosis of Cardiomyopathy: A Comprehensive Narrative Review. [PDF]
Jin Y+7 more
europepmc +1 more source
The systolic murmur in hypertrophic obstructive cardiomyopathy and the nature of the obstruction
M Nellen, Mervyn S. Gotsman
openalex +1 more source
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor+8 more
wiley +1 more source
Left ventricular thrombus in patient with nonischemic cardiomyopathy: A case report
Left ventricular thrombus (LVT) is a severe consequence that typically follows acute myocardial infarction (MI) and can occur in nonischemic cardiomyopathies.
Trang Thi Thao Pham, MD+8 more
doaj
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis. [PDF]
Schiavone M, Boriani G, Di Biase L.
europepmc +1 more source
Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. [PDF]
R E Fowles, C P Bieber, E. B. Stinson
openalex +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler+4 more
wiley +1 more source